315 related articles for article (PubMed ID: 16238703)
1. Epilepsy in children: the evidence for new antiepileptic drugs.
Verdru P
Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
[TBL] [Abstract][Full Text] [Related]
4. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
[TBL] [Abstract][Full Text] [Related]
7. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
Lai EC; Hsieh CY; Su CC; Yang YK; Huang CW; Lin SJ; Setoguchi S
Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857
[TBL] [Abstract][Full Text] [Related]
8. The new antiepileptic drugs.
Macleod S; Appleton RE
Arch Dis Child Educ Pract Ed; 2007 Dec; 92(6):182-8. PubMed ID: 18032714
[No Abstract] [Full Text] [Related]
9. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E
CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
[TBL] [Abstract][Full Text] [Related]
11. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
12. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drugs in the treatment of neuropathic pain.
Eisenberg E; River Y; Shifrin A; Krivoy N
Drugs; 2007; 67(9):1265-89. PubMed ID: 17547471
[TBL] [Abstract][Full Text] [Related]
14. New antiepileptic drugs in practice--how do they perform in the real world?
Sander JW
Acta Neurol Scand Suppl; 2005; 181():26-9. PubMed ID: 16238705
[TBL] [Abstract][Full Text] [Related]
15. What does the future hold for patients with epilepsy?
Faught E
Lancet Neurol; 2012 Apr; 11(4):298-300. PubMed ID: 22377179
[No Abstract] [Full Text] [Related]
16. Antiepileptic drugs for the elderly: using the old to focus on the new.
French JA; Chadwick DW
Neurology; 2005 Jun; 64(11):1834-5. PubMed ID: 15955930
[No Abstract] [Full Text] [Related]
17. Effects of antiepileptic drugs on cognition.
Aldenkamp AP
Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
[No Abstract] [Full Text] [Related]
18. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
[TBL] [Abstract][Full Text] [Related]
19. New antiepileptic drugs.
Bourgeois BF
Arch Neurol; 1998 Sep; 55(9):1181-3. PubMed ID: 9740111
[TBL] [Abstract][Full Text] [Related]
20. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
Yamauchi T; Kaneko S; Yagi K; Sase S
Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
